Finance · Search · Sign in · Sign up

Matilda buys NVO 46.17: Novo Nordisk A/S Receives Consensus Recommendation of “Buy” from Analysts (NYSE:NVO)


Novo Nordisk A/S (NYSE:NVO) has earned an average rating of “Buy” from the seven ratings firms that are currently covering the stock, AnalystRatingsNetwork.com reports. Three investment analysts have rated the stock with a hold rating and four have ... ...


64 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home